If you’re living with attention deficit/hyperactivity disorder (ADHD), learn more about the CAPSTONE research study of an investigational drug for adults with ADHD.
To pre-qualify for this study, you must:
• Be 18 to 55 years of age
• Be diagnosed or have been diagnosed with ADHD
All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. For more information about the CAPSTONE study, please contact Meridien Research at 813-563-6009 or complete the form below.